- Home
- FDMT vs EGY Comparison
FDMT vs EGY Comparison
Compare FDMT & EGY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDMT | EGY |
|---|---|---|
| Founded | 2013 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 515.6M | 652.7M |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | FDMT | EGY |
|---|---|---|
| Price | $9.69 | $5.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $31.71 | $7.30 |
| AVG Volume (30 Days) | 800.7K | ★ 1.7M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.39% |
| EPS Growth | ★ 18.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $85,209,000.00 | ★ $359,272,000.00 |
| Revenue This Year | N/A | $8.78 |
| Revenue Next Year | $70.28 | $29.81 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $2.96 | $3.14 |
| 52 Week High | $12.34 | $6.72 |
Technical Indicators
Market Signals| Indicator | FDMT | EGY |
|---|---|---|
| Relative Strength Index (RSI) | 54.04 | 41.18 |
| Support Level | $8.41 | $4.97 |
| Resistance Level | $10.69 | $6.72 |
| Average True Range (ATR) | 0.60 | 0.25 |
| MACD | -0.00 | -0.12 |
| Stochastic Oscillator | 56.38 | 2.80 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About EGY VAALCO Energy Inc.
VAALCO Energy Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil, natural gas, and natural gas liquids (NGLs). It has a diversified, African-focused portfolio of production, development, and exploration assets located in Gabon, Egypt, Cote d'Ivoire, Equatorial Guinea, and Nigeria, which are also considered its reportable operating segments. Maximum revenue is generated from the Gabon segment, which holds working interest in and operates the Etame Marin block, located offshore Gabon. The company derives all of its revenue from crude oil, natural gas, and natural gas liquids sales.